PharmaResearch Enters Brazilian Market with Rejuran Supply Agreement
PharmaResearch Co., Ltd. is making significant strides by signing an exclusive agreement for the supply of Rejuran with a prominent Brazilian aesthetic company. The company, well-regarded in the field, is readying itself for a robust entry into the dynamic Brazilian market.
Strategic Market Positioning in Brazilian Aesthetics
Brazil stands as the largest aesthetic market in Latin America, showcasing continuous growth in the demand for advanced aesthetic procedures and skin regeneration solutions. Recognizing this potential, PharmaResearch has strategically identified Brazil as pivotal for its objectives in regional expansion. The company is developing a comprehensive long-term market entry strategy to meet necessary regulatory approvals and local market requirements.
Partnership with DermaDream
Under this agreement, DermaDream will act as PharmaResearch's exclusive partner for distributing Rejuran throughout Brazil. DermaDream's established presence in the Brazilian aesthetic space, along with its robust distribution capabilities, positions PharmaResearch to fully tap into the local market.
Building Foundations for Future Growth
This strategic partnership enables PharmaResearch to lay a solid foundation for its entry into Brazil, ensuring compliance with all institutional and commercial protocols. The company aims to replicate its successful experiences in other South American markets, such as Chile and Peru, thereby solidifying its foothold in Latin America.
PharmaResearch’s Global Expansion Strategy
A PharmaResearch representative highlighted, "Brazil is pivotal in the Latin American aesthetic industry, and this agreement constitutes a crucial step in our global expansion ambitions." The company is committed to a careful, phased approach toward market development, always aligning with local regulatory structures.
International Partnerships for Enhanced Growth
PharmaResearch is actively collaborating with global partners to fuel its international growth strategy. Recently, the company forged a partnership agreement with Laboratoires VIVACY, a well-known French aesthetic firm, targeting an expansion across 22 European nations, principally in Western Europe, including key markets such as the United Kingdom, Germany, France, Italy, and Spain.
About PharmaResearch
PharmaResearch is a groundbreaking biopharmaceutical entity dedicated to enhancing life quality through innovations in regenerative medicine. Its diverse portfolio encompasses pharmaceuticals, medical devices, cosmetics, and dietary supplements, with a focus on utilizing core patented ingredients—DOT™ PDRN and DOT™ PN. The company is headquartered in Gangneung-si, Gangwon-do, South Korea, and includes a subsidiary in Costa Mesa, California.
Frequently Asked Questions
What is the main focus of PharmaResearch?
PharmaResearch focuses on enhancing quality of life through regenerative medicine and offers a diverse range of products, including medicines and medical devices.
Why is Brazil significant for PharmaResearch?
Brazil is the largest aesthetic market in Latin America, making it a key target for expanding PharmaResearch's global presence.
What is Rejuran?
Rejuran is a regenerative medicine product that PharmaResearch will supply through its partnership with DermaDream in Brazil.
How does PharmaResearch plan to enter the Brazilian market?
The company has developed a long-term strategy, partnering with local experts to ensure compliance with regulatory requirements while addressing market demands.
Who is DermaDream?
DermaDream is a leading aesthetic company in Brazil with extensive experience in product distribution and marketing, supporting PharmaResearch's market entry.
